Slideshow

Medical Nutrition Therapy for Dyslipidemia: Costs and Benefits

Author(s):

Veronica Hackethal MD

Medical nutrition therapy for hyperlipidemia management is widely recommended by clinical guidelines. Is it cost-effective?

Related Videos
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
The APAC Recap: Dyslipidemia at CAPP Live 2024 with Viet Le, DMSc, PA-C | Image Credit: APAC
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
Steve Nissen, MD | Credit: Cleveland Clinic
Related Content
FDA Approves Tirzepatide for Obstructive Sleep Apnea in Obesity | Image Credit: US Food and Drug Administration
December 20th 2024

FDA Approves Tirzepatide for Obstructive Sleep Apnea in Obesity

Connor Iapoce
Prof. Kausik Ray: Inclisiran Data at ESC Congress 2020
September 3rd 2020

Prof. Kausik Ray: Inclisiran Data at ESC Congress 2020

Patrick Campbell
CagriSema Achieves 22.7% Weight Loss in Phase 3 REDEFINE 1 Trial | Image Credit: Novo Nordisk
December 20th 2024

CagriSema Achieves 22.7% Weight Loss in Phase 3 REDEFINE 1 Trial

Connor Iapoce
The State of Preventive Cardiology
August 28th 2020

The State of Preventive Cardiology

Kevin Kunzmann
LIB Therapeutics Submits Lerodalcibep BLA Targeting Reduction in Elevated LDL-C | Image Credit: US Food and Drug Administration
December 19th 2024

LIB Therapeutics Submits BLA for Lerodalcibep Targeting Reductions in LDL-C

Connor Iapoce
HCPLive Cardiology Month in Review: November 2024
December 1st 2024

Cardiology Month in Review: November 2024

Patrick Campbell Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.